Novabay Pharmaceuticals, Inc. approved to elect Mijia (Bob) Wu Class I directors nominated by the Company's Board of Directors to hold office for a term of three (3) years or until their respective successors are elected and qualified.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0813 USD | +1.12% | -10.66% | -60.15% |
EPS Revisions
- Stock Market
- Equities
- NBY Stock
- News NovaBay Pharmaceuticals
- Novabay Pharmaceuticals, Inc. Approves to Elect Mijia Wu as Director